Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Ireland demands $1.9 billion in back taxes from Perrigo

Published 21/12/2018, 08:52
© Reuters. Birds are seen on the logo of generic drugmaker Perrigo Co outside their new factory in the city of Yeruham
AAPL
-
BIIB
-
PRGO
-

DUBLIN (Reuters) - Ireland's tax authorities have demanded that drugmaker Perrigo (N:PRGO), formerly known as Elan, pay 1.64 billion euros (1.48 billion pounds) in taxes relating to the calendar year 2013, a U.S. securities filing showed.

It is one of the biggest demands for back taxes ever made in Ireland, although well below EU antitrust regulators' demand in 2016 that Apple (NASDAQ:AAPL) pay the Irish government 13 billion euros.

According to the filing, Irish Revenue Commissioners say that intellectual property sales by Elan Pharma, including multiple sclerosis drug Tysabri, was taxed as trading income at 12.5 percent, when it should have been treated as a chargeable gain at a rate of 33 percent.

Dublin-based Perrigo, which is listed in New York, said in the filing that it strongly disputes the Revenue's assessment and will appeal.

It said the demand relates to the taxation of Elan Pharma's sales in April 2013 of Tysabri intellectual property and related assets to Biogen (NASDAQ:BIIB) Idec, eight months before Perrigo bought Elan.

Perrigo said the Irish Revenue Commissioners submitted an audit findings letter to Elan Pharma in October 2018 and invited the company to bring any areas of disagreement to the authority's attention, which led to a meeting with the tax authority and two written submissions.

"However, less than a month later — at a time when Perrigo believed that discussions concerning the matter were ongoing —Irish Revenue issued the NoA (Notice of Amended Assessment)," Perrigo said in the filing.

The Revenue Commissioners told Perrigo that no further information would be provided to clarify the basis of its assessment and that Perrigo should file its appeal by Dec. 28.

© Reuters. Birds are seen on the logo of generic drugmaker Perrigo Co outside their new factory in the city of Yeruham

In 2016, EU antitrust regulators' demanded that Apple pay 13 billion euros in taxes plus interest to the Irish government after ruling that a special scheme to route profits through Ireland was illegal state aid.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.